View Clinical Trial (Medical Research Study)

Cardiac Rhythm Abnormalities in Patients With Refractory Epilepsy at High Risk for Sudden Death - NCT00203333-19107(Clinical Trial 130157)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Philadelphia
State:  
PA
Zip Code: 19107
Conditions: Refractory Epilepsy - Arrhythmia - Sudden Death
Purpose: People with epilepsy are at a higher risk for sudden unexpected death than the general population. Sudden unexpected death in epilepsy (SUDEP) is a major cause of death in this population, accounting for 10-50% of deaths for those with epilepsy. The risk for SUDEP is particularly high for those with refractory epilepsy. Several lines of evidence support a cardiac mechanism for SUDEP. This study plans to determine: 1. the frequency and types of cardiac arrhythmias that occur in this population and 2. whether these are increased above the general population in the same age group. Additionally, these data will be correlated to specific clinical data, including seizure history, anticonvulsant medications, and any accompanying clinical symptoms.
Study summary: By employing long-term electrocardiographic monitoring, this study plans to determine: 1. the frequency and types of cardiac arrhythmias that occur in patients with uncontrolled seizures and 2. whether these are increased above the general population in the same age group. The specific aims: 1. Identify the types, frequency, and duration of cardiac arrhythmias that occur in patients with refractory epilepsy and compare these data to available normative data. 2. Correlate abnormal heart rates and rhythms to specific clinical data: 1. seizure type, 2. seizure frequency, 3. probable location of seizure onset in the brain, when such data are available, 4. duration of seizures, and 5. type(s) and number of anticonvulsant medications being used. 3. Correlate cardiac arrhythmias to clinical symptoms
Criteria: Inclusion Criteria: - Refractory epilepsy Exclusion Criteria: - Other pre-existing heart conditions
Study is available at: Thomas Jefferson University
Philadelphia, PA 19107
United States

Primary Contact:
Megan Morales, BA
Email: megan.morales@jefferson.edu
Phone: 215-955-4672

Secondary Contact:
Gwen Taylor, BA
Email: gwen.taylor@jefferson.edu
Phone: 215-955-4673
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 21, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.